T-cadherin, a major adiponectin binding partner, suppresses ERK signaling in metabolic tissues
Abstract
T-cadherin, which is a major adiponectin binding partner, exerts various organ-protective effects. However, the specific changes in intracellular signaling that are induced by T-cadherin in metabolic tissues/cells remain unclear. We demonstrated that T-cadherin suppresses ERK signaling in both cultured cells and murine tissues. T-cadherin knockdown increased ERK phosphorylation in C2C12 myocytes and F2 endothelial cells, whereas T-cadherin overexpression suppressed ERK phosphorylation. Proteomic analysis revealed that many proteins that are downstream targets of ERK signaling were upregulated by T-cadherin knockdown in myocytes. T-cadherin knockdown in myocytes or knockout in heart or skeletal muscles altered the levels of membrane proteins that are involved in signal transduction, including IGF1R and EGFR. Ablation of T-cadherin in mice was accompanied by increased ERK signaling, leading to increased cardiac hypertrophy and decreased appropriate muscle atrophy during starvation. Thus, T-cadherin, whose protein expression is maintained by adiponectin, modulates intracellular signaling and regulates cardiac and skeletal muscle homeostasis in addition to promoting exosome production by adiponectin.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Hirofumi Nagao
Department of Metabolism and Atherosclerosis, Graduate School of Medicine, The University of Osaka
Yuta Kondo
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Keitaro Kawada
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Yuya Fujishima
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Shunsuke Shiode
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Yuhei Uehara
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Shiro Fukuda
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Yoshinari Obata
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Shunbun Kita
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka
Hitoshi Nishizawa
Department of Metabolism and Atherosclerosis, Graduate School of Medicine, The University of Osaka
Iichiro Shimomura
Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka